Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 4
2003 7
2004 6
2005 4
2006 2
2007 2
2008 8
2009 9
2010 12
2011 4
2012 7
2013 4
2015 5
2016 4
2017 7
2018 5
2019 9
2020 5
2021 6
2022 6
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Results by year

Filters applied: . Clear all
Page 1
MuSyC dosing of adjuvanted cancer vaccines optimizes antitumor responses.
Taylor D, Meyer CT, Graves D, Sen R, Fu J, Tran E, Mirza B, Rodriguez G, Lang C, Feng H, Quaranta V, Wilson JT, Kim YJ, Korrer MJ. Taylor D, et al. Among authors: quaranta v. Front Immunol. 2022 Aug 19;13:936129. doi: 10.3389/fimmu.2022.936129. eCollection 2022. Front Immunol. 2022. PMID: 36059502 Free PMC article.
Archetype tasks link intratumoral heterogeneity to plasticity and cancer hallmarks in small cell lung cancer.
Groves SM, Ildefonso GV, McAtee CO, Ozawa PMM, Ireland AS, Stauffer PE, Wasdin PT, Huang X, Qiao Y, Lim JS, Bader J, Liu Q, Simmons AJ, Lau KS, Iams WT, Hardin DP, Saff EB, Holmes WR, Tyson DR, Lovly CM, Rathmell JC, Marth G, Sage J, Oliver TG, Weaver AM, Quaranta V. Groves SM, et al. Among authors: quaranta v. Cell Syst. 2022 Sep 21;13(9):690-710.e17. doi: 10.1016/j.cels.2022.07.006. Epub 2022 Aug 17. Cell Syst. 2022. PMID: 35981544 Free PMC article.
Activation of STAT3 through combined SRC and EGFR signaling drives resistance to a mitotic kinesin inhibitor in glioblastoma.
Kenchappa RS, Dovas A, Argenziano MG, Meyer CT, Stopfer LE, Banu MA, Pereira B, Griffith J, Mohammad A, Talele S, Haddock A, Zarco N, Elmquist W, White F, Quaranta V, Sims P, Canoll P, Rosenfeld SS. Kenchappa RS, et al. Among authors: quaranta v. Cell Rep. 2022 Jun 21;39(12):110991. doi: 10.1016/j.celrep.2022.110991. Cell Rep. 2022. PMID: 35732128 Free PMC article.
110 results